前收市價 | 6.35 |
開市 | 7.26 |
買盤 | 6.15 |
賣出價 | 7.00 |
拍板 | 10.00 |
到期日 | 2026-01-16 |
今日波幅 | 7.20 - 7.41 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 220 |
The biotech stock is feeling the heat from an indictment of a former consultant.
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
In 2024, the iShares Biotechnology ETF (NASDAQ:IBB) is up just over 1.5%. If you’re looking for steady, dividend-paying stocks, you can find a number of biotech stocks to buy from the holdings in this fund. However, if you’re looking for the chance to turn a modest investment into, perhaps, generational wealth, the list becomes narrower and carries a lot more risk. But it’s exactly that risk/reward relationship that makes it an attractive sector for speculative investors. Investing in biotech st